Lung cancer related methylation gene combination in plasma and application of lung cancer related methylation gene combination
A technology of gene combination and methylation, which is applied in the combination of lung cancer-related methylation genes in plasma and its application fields, can solve the problems of inapplicability and insufficient stability of the method
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0074] Example 1: Detection of DNA methylation by real-time fluorescent PCR, design and verification of primer probe set
[0075] This embodiment provides a method and process for designing a primer-probe set including six lung cancer-related genes SHOX2, CDO1, PTGER4, TAC1, HOXA7, and SCT and an internal reference GAPDH;
[0076] This example also provides a method and kit for detecting the methylation of lung cancer-related genes in plasma, which can be used for screening and auxiliary diagnosis of lung cancer and early lung cancer. The test results are verified by negative reference products and positive reference products. Verify the primer-probe set designed above.
[0077] Specific steps are as follows:
[0078] 1. Query the 6 lung cancer-related genes and the internal reference GAPDH sequence:
[0079] Lung cancer-related genes SHOX2, CDO1, PTGER4, TAC1, HOXA7, and SCT and the internal reference GAPDH were queried through the National Center for Biotechnology Informat...
Embodiment 2
[0123] Example 2: Construction of target relative methylation standard linear equation
[0124] Preparation of SHOX2 / CDO1 relative methylation degree reference product with GAPDH as reference, mainly including methylation degree of 100% (10 5 copies / ul (SHOX2): 10 5 copies / ul(CDO1): 10 5 copies / ul(GAPDH)), 10% (10 4 copies / ul(SHOX2):10 4 copies / ul (CDO1): 10 5 copies / ul(GAPDH)), 1% (10 3 copies / ul(SHOX2):10 3 copies / ul(CDO1):10 5 copies / ul(GAPDH)), 0.1% (10 2 copies / ul(SHOX2):10 2 copies / ul(CDO1):10 5 copies / ul(GAPDH)), 0.01% (10 1 copies / ul(SHOX2): 10 1 copies / ul(CDO1):10 5 copies / ul(GAPDH)). The relative methylation reference products of the genes of the other four lung cancers are prepared in the same way as SHOX2 / CDO1, so details are not repeated here.
[0125] Using the above-mentioned serially diluted DNA template, carry out qPCR experiment, the reaction system is as follows:
[0126] Table 3 SHOX2 / CDO1 relative methylation detection reaction system
[01...
Embodiment 3
[0131] Example 3: Validation of clinical sensitivity and clinical specificity of 6 different lung cancer methylation gene joint detection kits in detection of lung cancer patients and normal human plasma
[0132] This example judges the clinical sensitivity of the gene combinations selected in this kit by verifying the DNA methylation status of different combinations of 6 lung cancer-related methylation genes in lung cancer plasma and the methylation status of plasma cell-free DNA in normal human plasma and clinical specificity.
[0133] Plasma cell-free DNA extraction:
[0134] use Serum / Plasma Circulating DNA Kit (purchased from Nanjing Novizan Biotechnology Co., Ltd., Cat. No. N902-01), operated according to the kit instructions.
[0135] Plasma cell-free DNA bisulfite conversion:
[0136] The sulfite conversion was carried out according to the instruction manual of the EZ DNA Methylation-DirectTM KIT (D5031) of the ZYMO RESEARCH biological company kit. Amplification a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com